Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia
暂无分享,去创建一个
Mark A Westwood | Dudley J Pennell | David N Firmin | Peter D Gatehouse | D. Pennell | C. Lorenz | D. Firmin | L. Anderson | P. Gatehouse | M. Westwood | Christine H Lorenz | Beatrix Wonke | Lisa J Anderson | B. Wonke
[1] Matthew Darlison,et al. Survival in β-thalassaemia major in the UK: data from the UK Thalassaemia Register , 2000, The Lancet.
[2] J. Porter,et al. Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk β-thalassemia , 2000 .
[3] A. Piga,et al. SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJOR , 1989, The Lancet.
[4] E R McVeigh,et al. In vivo measurement of T*2 and field inhomogeneity maps in the human heart at 1.5 T , 1998, Magnetic resonance in medicine.
[5] D. Halperin,et al. Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassemia major. , 1993, Chest.
[6] D. Pennell,et al. Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia , 2002, The Lancet.
[7] D N Firmin,et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. , 2001, European heart journal.
[8] J. H. MacMillan,et al. Survival in medically treated patients with homozygous beta-thalassemia. , 1994, The New England journal of medicine.
[9] D J Pennell,et al. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. , 2000, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[10] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[11] D. Pennell,et al. Breath-hold FLASH and FISP cardiovascular MR imaging: left ventricular volume differences and reproducibility. , 2002, Radiology.
[12] A. Hoffbrand,et al. High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation. , 1990, Acta haematologica.
[13] J. H. MacMillan,et al. Survival in Medically Treated Patients with Homozygous β-Thalassemia , 1994 .